Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383746857> ?p ?o ?g. }
- W4383746857 endingPage "1085" @default.
- W4383746857 startingPage "1076" @default.
- W4383746857 abstract "Although microwave ablation (MWA) has a low complication rate and good efficacy for small-size (≤ 3 cm) colorectal liver metastases (CRLM), local control decreases with increasing size. Stereotactic body radiotherapy (SBRT) is gaining interest as a potential means to treat intermediate-size CRLM and might be less susceptible to increasing volume. The objective of this study is to compare the efficacy of MWA to SBRT in patients with unresectable, intermediate-size (3-5 cm) CRLM.In this two-arm, multicentre phase II/ III randomized controlled trial, 68 patients with 1-3 unresectable, intermediate-size CRLM suitable for both MWA and SBRT, will be included. Patients will be treated with MWA or SBRT as randomised. The Primary endpoint is local tumour progression-free survival (LTPFS) at 1 year (intention-to-treat analysis). Main secondary endpoints are overall survival, overall and distant progression-free survival (DPFS), local control (LC) and procedural morbidity and mortality and assessment of pain and quality of life.Current guidelines lack clear recommendations for the local treatment of liver only intermediate-size, unresectable CRLM and studies comparing curative intent SBRT and thermal ablation are scarce. Although safety and feasibility to eradicate tumours ≤ 5 cm have been established, both techniques suffer from lower LTPFS and LC rates for larger-size tumours. For the treatment of unresectable intermediate-size CRLM clinical equipoise has been reached. We have designed a two-armed phase II/ III randomized controlled trial directly comparing SBRT to MWA for unresectable CRLM 3-5 cm.Level 1, phase II/ III Randomized controlled trial.NCT04081168, September 9th 2019." @default.
- W4383746857 created "2023-07-11" @default.
- W4383746857 creator A5000208694 @default.
- W4383746857 creator A5000365256 @default.
- W4383746857 creator A5000432025 @default.
- W4383746857 creator A5000607523 @default.
- W4383746857 creator A5000763487 @default.
- W4383746857 creator A5000953666 @default.
- W4383746857 creator A5001238315 @default.
- W4383746857 creator A5004755566 @default.
- W4383746857 creator A5007268728 @default.
- W4383746857 creator A5007311016 @default.
- W4383746857 creator A5007976032 @default.
- W4383746857 creator A5008861959 @default.
- W4383746857 creator A5010065978 @default.
- W4383746857 creator A5010139091 @default.
- W4383746857 creator A5012099255 @default.
- W4383746857 creator A5016264919 @default.
- W4383746857 creator A5017926406 @default.
- W4383746857 creator A5018448894 @default.
- W4383746857 creator A5020097565 @default.
- W4383746857 creator A5021133509 @default.
- W4383746857 creator A5022156712 @default.
- W4383746857 creator A5022352601 @default.
- W4383746857 creator A5023259244 @default.
- W4383746857 creator A5023994552 @default.
- W4383746857 creator A5024066538 @default.
- W4383746857 creator A5024258757 @default.
- W4383746857 creator A5024500835 @default.
- W4383746857 creator A5026448991 @default.
- W4383746857 creator A5028968889 @default.
- W4383746857 creator A5034230371 @default.
- W4383746857 creator A5035081418 @default.
- W4383746857 creator A5035435527 @default.
- W4383746857 creator A5036810185 @default.
- W4383746857 creator A5036824467 @default.
- W4383746857 creator A5037434235 @default.
- W4383746857 creator A5037533889 @default.
- W4383746857 creator A5040951572 @default.
- W4383746857 creator A5041935065 @default.
- W4383746857 creator A5043290919 @default.
- W4383746857 creator A5044344644 @default.
- W4383746857 creator A5045147328 @default.
- W4383746857 creator A5046471302 @default.
- W4383746857 creator A5046471696 @default.
- W4383746857 creator A5046527982 @default.
- W4383746857 creator A5048947968 @default.
- W4383746857 creator A5055225500 @default.
- W4383746857 creator A5057251186 @default.
- W4383746857 creator A5058817785 @default.
- W4383746857 creator A5059031922 @default.
- W4383746857 creator A5060176696 @default.
- W4383746857 creator A5063405106 @default.
- W4383746857 creator A5063475781 @default.
- W4383746857 creator A5064209010 @default.
- W4383746857 creator A5064280465 @default.
- W4383746857 creator A5066101772 @default.
- W4383746857 creator A5066674954 @default.
- W4383746857 creator A5067039906 @default.
- W4383746857 creator A5069521698 @default.
- W4383746857 creator A5070367929 @default.
- W4383746857 creator A5073795542 @default.
- W4383746857 creator A5074964050 @default.
- W4383746857 creator A5075241928 @default.
- W4383746857 creator A5077391436 @default.
- W4383746857 creator A5077817690 @default.
- W4383746857 creator A5078316873 @default.
- W4383746857 creator A5079878171 @default.
- W4383746857 creator A5080015264 @default.
- W4383746857 creator A5081968529 @default.
- W4383746857 creator A5083275019 @default.
- W4383746857 creator A5083943954 @default.
- W4383746857 creator A5083965592 @default.
- W4383746857 creator A5086810045 @default.
- W4383746857 creator A5087380365 @default.
- W4383746857 creator A5088673015 @default.
- W4383746857 creator A5090097123 @default.
- W4383746857 creator A5092437652 @default.
- W4383746857 creator A5092437653 @default.
- W4383746857 date "2023-07-10" @default.
- W4383746857 modified "2023-10-03" @default.
- W4383746857 title "Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial" @default.
- W4383746857 cites W1976550982 @default.
- W4383746857 cites W1977503091 @default.
- W4383746857 cites W1979485825 @default.
- W4383746857 cites W2002901680 @default.
- W4383746857 cites W2004673269 @default.
- W4383746857 cites W2014683369 @default.
- W4383746857 cites W2034284109 @default.
- W4383746857 cites W2035964293 @default.
- W4383746857 cites W2036672856 @default.
- W4383746857 cites W2039467075 @default.
- W4383746857 cites W2040357326 @default.
- W4383746857 cites W2043039948 @default.
- W4383746857 cites W2043489823 @default.
- W4383746857 cites W2046559051 @default.
- W4383746857 cites W2055407227 @default.
- W4383746857 cites W2057156320 @default.